CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients

ACC 2018 – Wrap Up in German

TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients

ACC 2018 – Wrap Up from a Pacific Rim Perspective

ACC 2018 – Wrap Up from a Canadian Perspective

ACC 2018 Wrap-up in Arabic

CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients

ACC 2018 Daily Wrap-Up – March 11, 2018

ACC 2018 Hebrew Wrap Up

ACC 2018 Wrap-Up: Prof. Freek Verheugt’s Perspective

ACC 2018 Japanese Wrap-Up

ACC 2018 Italian Wrap Up

MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery

ODYSSEY Outcomes: Alirocumab Reduces MACE, Non-fatal MI, Ischemic Stroke, and All-Cause Mortality in ACS Patients

VEST trial: Prevention of Early Sudden Death Post-MI

SWAP 4: Pharmacodynamic Effects of Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease

ACC 2018 Daily Wrap-Up – March 10, 2018

ACC 2018Acute Coronary SyndromeConferencesNews

ODYSSEY Demonstrates a Mortality Benefit in ACS Patients

Results of the much anticipated ODYSSEY Outcomes trial were presented today by…

Incorporating Non-Invasive Fractional Flow Reserve into Clinical Practice

Anticipating ODYSSEY Outcomes